Robitussin CoughGels Long-Acting (dextromethorphan HBr) | ROBITUSSIN COUGH GELS LONG-ACTING
Dextromethorphan HBr, USP 15 mg
temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold.
cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
|adults and children 12 years and over||take 2 capsules every 6 to 8 hours, as needed|
|children under 12 years||do not use|
FD&C blue no. 1, FD&C red no. 40, gelatin, glycerin, mannitol, medium chain triglycerides, pharmaceutical ink, polyethylene glycol, povidone, propyl gallate, propylene glycol, purified water, sorbitol, sorbitol anhydrides
Call weekdays from 9 AM to 5 PM EST at 1-800-762-4675
The product packaging shown below represents a sample of that currently in use. Additional packaging may also be available.
See New Dosing Information
DEXTROMETHORPHAN HBr (Cough Suppressant)
Up to 8 Hours of Cough Relief
For Ages 12 & Over
Liquid-Filled Capsules You Just Swallow
PARENTS: Learn about teen medicine abuse www.StopMedicineAbuse.org
Distributed by Wyeth Consumer Healthcare
Madison, NJ 07940 U.S.A. ©2008 Wyeth
For most recent product information, visit www.robitussin.com
Liqui-Gels is a trademark or registered trademark of Catalent Pharma Solutions
Richmond Division of Wyeth
Drugs and Medications
Robitussin Lingering Cold Long-Acting CoughGels(dextromethorphan HBr)
Robitussin Cough Long-Acting (dextromethorphan HBr)
Robitussin Cough & Cold Long-Acting(chlorpheniramine maleate and dextromethorphan HBr)
Children’s Robitussin Cough & Cold Long-Acting(chlorpheniramine maleate and dextromethorphan HBr)
Children’s Robitussin Cough Long-Acting(dextromethorphan HBr)
This is a multi-center extension of Alkermes study ALK21-006 to further assess the long-term safety of repeat monthly doses of naltrexone long acting injection.
This study is being done to find out why some people with mucus dripping down the back of their throat have a nagging cough while others do not cough.
This trial is conducted in Asia, Europe, Japan and North America. The aim of this clinical trial is to investigate the safety and the efficacy of a prophylactic treatment option with long...
A cough lasting more than 2 months is known as a chronic cough, affecting 12-23% of the adult non-smoking population. Chronic cough has many associated complications including incontinenc...
The purpose of this study is to compare therapeutic effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting one, in patients with heart failure, and to test our h...
ABSTRACT BACKGROUND: Currently no data is available on the relationship between changes in objective and subjective measures of cough, the magnitude of change in cough frequency perceived by patients...
INTRODUCTION: Assessment of the reflux-cough association in children is challenging. Esophageal (impedance) pH recording is sensitive to recognize reflux. However, cough recorded by an event marker, p...
ABSTRACT: BACKGROUND: Chronic idiopathic cough (known as cough hypersensitivity syndrome) is defined by cough in the absence of an identifiable cause. Gabapentin has been suggested as a treatment but...
ABSTRACT: Rationale Speech language pathology is an effective management intervention for chronic cough that persists despite medical treatment. The mechanism behind the improvement has not been deter...
AIM: There are sound reasons for considering the use of long-acting injectable antipsychotics early in the course of schizophrenia. We reviewed available literature on the subject. METHOD: We conducte...